Equity Profile

MDLN

Medline Inc.

Health CareHealth Care Supplies$31.2B

Aug5Wed

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Medline Inc. is a major player in the health care supplies sector, providing a wide range of medical products and services....

Key Metrics to Watch

Revenue Growth

Revenue growth is critical for assessing Medline's ability to expand its market share and meet increasing demand in the healthcare sector.

N/A

Earnings Per Share (EPS)

EPS is a key indicator of profitability and will help investors gauge the company's financial health this quarter.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

MDLN Q2-2026 Earnings Preview

Context

Company Snapshot

Medline Inc. is a major player in the health care supplies sector, providing a wide range of medical products and services. With a market cap of $31 billion, the company plays a crucial role in supporting hospitals and healthcare providers, especially as demand for health care services continues to grow.

Earnings Scorecard·Last 2Q

EPS Beat Streak

EPS Beat Rate

50%

Avg EPS Surprise

-45.61%

Avg Stock Reaction

-5.46%

Last Quarter Recap

In Q1-2026, Medline reported an EPS of $0.33, exceeding expectations by 13%. However, the stock declined by 7.30% the following day, indicating mixed investor sentiment.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts are cautious ahead of Medline's earnings report, given the mixed results from previous quarters. Investors are looking for signs of recovery and growth.

Bull Case

If Medline can demonstrate strong revenue growth and improved margins, it could signal a turnaround and boost investor confidence.

Bear Case

Conversely, if the company fails to meet expectations or shows signs of declining profitability, it could lead to further stock price declines.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the expected revenue growth rate for this quarter?

Revenue growth will be a key indicator of Medline's ability to capitalize on market demand and improve its financial outlook.

How has the gross margin changed compared to previous quarters?

Changes in gross margin will provide insight into operational efficiency and pricing strategies, which are crucial for profitability.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Medline's potential for revenue growth due to increased demand for healthcare supplies, especially post-pandemic.

Supporting Evidence

The company has a strong market position that could lead to better-than-expected sales.

Options pricing suggests a significant move, indicating that investors are anticipating volatility, which could favor a positive outcome.

Key Risk

If revenue growth exceeds 10%, it could challenge the current cautious sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will hinge on Medline's ability to navigate market challenges and deliver strong financial results.

Bull Confirmed If

Demonstrating revenue growth of at least 10% year-over-year would confirm the bullish case for Medline.

Bear Confirmed If

If revenue growth falls below 5%, it would support the bearish outlook.

Pre-Earnings Positioning

Options Market

Implied Move

±17.64%

The options market is pricing in a significant move, suggesting that investors anticipate volatility around the earnings announcement.

Detail

ATM IV

0.5%

30d HV

44.4%

Calls (41K)P/C Ratio: 0.13Puts (3K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat setup in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Medline beats expectations, history suggests the stock could rise by around 5.46%, confirming a positive trend.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further guidance.

Miss

A miss could lead to a decline of about 3.62%, reflecting ongoing concerns about the company's performance.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on revenue growth projections for the upcoming quarters.
2Details on cost management strategies and their impact on gross margins.
3Insights into market demand trends for healthcare supplies.
4Comments on competitive positioning within the industry.
5Any changes in guidance or outlook for the remainder of the fiscal year.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Medline Inc. is a major player in the health care supplies sector, providing a wide range of medical products and services....

Key Metrics to Watch

Revenue Growth

Revenue growth is critical for assessing Medline's ability to expand its market share and meet increasing demand in the healthcare sector.

N/A

Earnings Per Share (EPS)

EPS is a key indicator of profitability and will help investors gauge the company's financial health this quarter.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

MDLN Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 2Q

EPS Beat Streak

EPS Beat Rate

50%

Avg EPS Surprise

-45.61%

Avg Stock Reaction

-5.46%

Last Quarter Recap

In Q1-2026, Medline reported an EPS of $0.33, exceeding expectations by 13%. However, the stock declined by 7.30% the following day, indicating mixed investor sentiment.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts are cautious ahead of Medline's earnings report, given the mixed results from previous quarters. Investors are looking for signs of recovery and growth.

Bull Case

If Medline can demonstrate strong revenue growth and improved margins, it could signal a turnaround and boost investor confidence.

Bear Case

Conversely, if the company fails to meet expectations or shows signs of declining profitability, it could lead to further stock price declines.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the expected revenue growth rate for this quarter?

Revenue growth will be a key indicator of Medline's ability to capitalize on market demand and improve its financial outlook.

How has the gross margin changed compared to previous quarters?

Changes in gross margin will provide insight into operational efficiency and pricing strategies, which are crucial for profitability.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Medline's potential for revenue growth due to increased demand for healthcare supplies, especially post-pandemic.

Supporting Evidence

The company has a strong market position that could lead to better-than-expected sales.

Options pricing suggests a significant move, indicating that investors are anticipating volatility, which could favor a positive outcome.

Key Risk

If revenue growth exceeds 10%, it could challenge the current cautious sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will hinge on Medline's ability to navigate market challenges and deliver strong financial results.

Bull Confirmed If

Demonstrating revenue growth of at least 10% year-over-year would confirm the bullish case for Medline.

Bear Confirmed If

If revenue growth falls below 5%, it would support the bearish outlook.

Pre-Earnings Positioning

Options Market

Implied Move

±17.64%

The options market is pricing in a significant move, suggesting that investors anticipate volatility around the earnings announcement.

Detail

ATM IV

0.5%

30d HV

44.4%

Calls (41K)P/C Ratio: 0.13Puts (3K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat setup in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Medline beats expectations, history suggests the stock could rise by around 5.46%, confirming a positive trend.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further guidance.

Miss

A miss could lead to a decline of about 3.62%, reflecting ongoing concerns about the company's performance.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on revenue growth projections for the upcoming quarters.
2Details on cost management strategies and their impact on gross margins.
3Insights into market demand trends for healthcare supplies.
4Comments on competitive positioning within the industry.
5Any changes in guidance or outlook for the remainder of the fiscal year.